✦ LIBER ✦

Orthotopic liver transplantation for acute grade IV hepatic graft-versus-host disease following bone marrow transplantation

✍ Scribed by Figuera, Angela; Tomás, José F.; Otero, Mariá J.; Moreno, Enrique; García, Ismael; Fernández-Rañada, José M.

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 242 KB
Volume: 52
Category: Article
ISSN: 0361-8609
DOI: 10.1002/(sici)1096-8652(199605)52:1<68::aid-ajh19>3.0.co;2-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multivariate approach for assessing se

A multivariate approach for assessing severity of acute graft-versus-host disease in bone marrow transplantation

✍ Rudolph S. Parrish; Linda J. Hazlett; Kerry D. Bridges; P. Jean Henslee-Downey 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 2 views

Patients undergoing bone marrow transplantation are at high risk of developing acute graft-versus-host disease (GVHD) which is a primary limiting factor for this procedure inasmuch as it is responsible for high morbidity rates and is associated with poor survival outcome. To provide improved treatme

Reduced intensity conditioning allogenei

Reduced intensity conditioning allogeneic bone marrow transplantation following central nervous system (CNS) relapse of acute promyelocytic leukemia: Evidence for a graft-versus-leukemia effect in the CNS

✍ M. Ostronoff; M.C. Domingues; F. Ostronoff; C. Matias; R. Florêncio; K. Matias; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

Expression of CD134 (0X-40) on T cells d

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease

✍ L.S. Lamb Jr; S.A. Abhyankar; L. Hazlett; W. O'Neal; R.S. Folk; S. Vogt; R.S. Pa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4؉ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets